Thymosin Beta-4 Peptide – User Manual & Research Protocol Guide

Thymosin Beta-4 (TB-4) is a naturally occurring peptide studied for its role in cell migration, tissue repair, and regenerative signaling. In research environments, it is commonly investigated for wound healing pathways, angiogenesis, and cytoskeletal organization in regenerative biology models.

Research Applications

Tissue repair and regeneration studies
Cell migration and differentiation research
Angiogenesis and vascular development models
Inflammatory response modulation
Muscle and connective tissue recovery models

Disclaimer: Thymosin Beta-4 is for research and experimental use only and is not FDA-approved for therapeutic use.

Lyophilized Powder
Freeze-dried Thymosin Beta-4 for reconstitution

Reconstituted Solution
Injectable research preparation after reconstitution

Thymosin Beta-4 is studied for its ability to:

• Promote cell migration and tissue remodeling pathways
• Support angiogenesis in experimental models
• Regulate actin polymerization in cellular structure
• Modulate inflammatory signaling responses
• Support regenerative repair mechanisms

Observed effects are derived from preclinical and investigational research settings.

Subcutaneous (SC) – Standard Research Model

Typical research protocols use 2–5 mg per administration, generally 2–3 times weekly, often in regenerative research models.

Short-Course Research

Some studies use 2–5 mg weekly for limited-duration protocols.

Localized Research Model

Dosing is protocol-dependent with variable frequency, typically used in targeted tissue studies.

Important

There is no approved human dosage. The ranges above reflect commonly cited research patterns only.

Initiation

A 1–2 week phase used for initial response observation at the start of the study.

Active Study Phase

Typically 4–8 weeks, focused on evaluating regenerative pathways.

Rest Period

A 4+ week interval between study cycles to allow recovery and system reset.

Note

Cycle duration may vary depending on study design and research endpoints.

Supplies

Sterile bacteriostatic water
Sterile syringe
Alcohol swabs

General Procedure

1. Clean vial stopper with alcohol.
2. Add bacteriostatic water to desired concentration.
   Example: 5 mg vial + 2 mL → 2.5 mg/mL
3. Swirl gently to dissolve (do not shake).
4. Refrigerate at 2–8°C after reconstitution.
5. Use within 2–4 weeks or per protocol.

Maintain sterile technique
Rotate administration sites in injectable models
Document preparation concentration and date
Follow institutional research standards

Lyophilized Powder

Store in a cool, dry environment to maintain stability, with a shelf life of up to 12 months.

Reconstituted Solution

Keep refrigerated at 2–8°C and use within 2–4 weeks after preparation.

Protection Guidelines

Protect from light, heat, and contamination to preserve quality.

Safety Note

Discard the solution if it becomes cloudy or discolored, as this may indicate contamination or degradation.

Research use only
Not for therapeutic application
Human safety outside controlled research is not established
Potential research observations: injection-site irritation
Maintain sterile handling technique
Keep out of reach of unauthorized personnel

Peptide: Thymosin Beta-4
Category: Healing & Regenerative Research
Delivery: Injectable research model
Typical Investigational Range: 2–5 mg per administration
Cycle: 4–8 week research protocols
Storage: Refrigerated after reconstitution